Avidity Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Name: Avidity Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Avidity Biosciences Inc
Rating: 1.72825
Author: Trendlyne DVM scores

about

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical...

46.58 -2.00 (-4.12%)

116.55% Gain from 52W Low

1.4M

XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

5.5 / 100

Technically Moderately Bullish

63.6 / 100

1Yr Price target upside is 44%

18 analysts

Avidity Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Avidity Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical...

116.55% Gain from 52W Low

SWOT Analysis

Avidity Biosciences Inc Live Price Chart